Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) EPS (Basic): 2018-2024

Historic EPS (Basic) for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$3.

  • Arcturus Therapeutics Holdings' EPS (Basic) fell 88.46% to -$0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.46, marking a year-over-year decrease of 5.13%. This contributed to the annual value of -$3 for FY2024, which is 167.86% down from last year.
  • According to the latest figures from FY2024, Arcturus Therapeutics Holdings' EPS (Basic) is -$3, which was down 167.86% from -$1.12 recorded in FY2023.
  • In the past 5 years, Arcturus Therapeutics Holdings' EPS (Basic) registered a high of $0.35 during FY2022, and its lowest value of -$7.74 during FY2021.
  • Moreover, its 3-year median value for EPS (Basic) was -$1.12 (2023), whereas its average is -$1.26.
  • Its EPS (Basic) has fluctuated over the past 5 years, first soared by 104.52% in 2022, then tumbled by 420.00% in 2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' EPS (Basic) (Yearly) stood at -$3.55 in 2020, then tumbled by 118.03% to -$7.74 in 2021, then soared by 104.52% to $0.35 in 2022, then plummeted by 420.00% to -$1.12 in 2023, then crashed by 167.86% to -$3 in 2024.